Skip to main content

Table 1 Correlation between coNLR-PDW and clinicopathological features or hematological parameters

From: Prognostic value of inflammation-based indices in patients with resected hepatocellular carcinoma

Variables

Number of patients

co NLR-PDW 0

co NLR-PDW 1

co NLR-PDW 2

P-value

Age, < 60/≥60 years

194/56

31/11

108/35

55/10

0.281

Gender, male/female

225/25

36/6

129/14

60/5

0.536

HBsAg, negative/positive

29/221

5/37

17/126

7/58

0.971

Cirrhosis, no/yes

79/171

21/21

42/99

16/44

0.004

Tumor size, ≤5/> 5 cm

137/113

31/11

69/74

37/28

0.013

Tumor number, single/multiple

179/71

32/10

99/44

48/17

0.609

AFP, < 400/≥400 ng/ml

170/80

26/16

98/45

46/19

0.617

Vascular invasion, no/yes

146/104

28/14

77/66

41/24

0.225

Child-Pugh grade, A/B

235/15

41/1

137/6

57/8

0.041

BCLC, 0-A/ B-C

19/79/48/104

23/19

50/93

25/40

0.069

Differentiation, well moderate/poor

41/189/20

40/2

130/13

60/5

0.658

PT (s)

13.6 (12.9–14.2)

13.4 (12.7–14.1)

13.6 (13.0–14.4)

13.5 (13.1–14.2)

0.143

ALT (U/L)

38.0 (26.0–52.3)

35.0 (22.5–46.5)

40.0 (27.8–57.5)

39.0 (26.0–50.0)

0.093

TB (umol/L)

14.7 (10.7–18.3)

13.9 (9.8–16.0)

14.3 (10.8–18.2)

15.8 (12.4–20.5)

0.032

GGT (U/L)

60.5 (37.0–117.5)

49.0 (26.0–98.0)

64.5 (38.0–119.5)

70.0 (43.0–135.0)

0.055

ALB (g/L)

40.0 ± 4.2

40.3 ± 3.7

39.5 ± 4.1

41.0 ± 4.6

0.053

MPV (Fl)

10.6 (9.9–11.2)

9.8 (9.4–10.2)

10.6 (10.0–11.2)

11.2 (10.8–11.6)

< 0.001

  1. Notes: AFP alpha fetoprotein, BCLC Barcelona Clinic Liver Cancer, PT prothrombin time, ALT Alanine transaminase, TB total bilirubin, GGT gamma-glutamyl transpeptidase, ALB albumin, MPV mean platelet volume, coNLR-PDW combination of NLR and PDW